Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2009 | 1 |
2010 | 1 |
2011 | 1 |
2012 | 1 |
2019 | 2 |
2023 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
Page 1
Retraction: Carfilzomib Interacts Synergistically with Histone Deacetylase Inhibitors in Mantle Cell Lymphoma Cells In Vitro and In Vivo.
Mol Cancer Ther. 2019 Jun;18(6):1179. doi: 10.1158/1535-7163.MCT-19-0469.
Mol Cancer Ther. 2019.
PMID: 31160509
Free PMC article.
No abstract available.
Retraction: Obatoclax Interacts Synergistically with the Irreversible Proteasome Inhibitor Carfilzomib in GC- and ABC-DLBCL Cells In Vitro and In Vivo.
Dasmahapatra G, Lembersky D, Son MP, Patel H, Peterson D, Attkisson E, Fisher RI, Friedberg JW, Dent P, Grant S.
Dasmahapatra G, et al. Among authors: lembersky d.
Mol Cancer Ther. 2019 Jun;18(6):1180. doi: 10.1158/1535-7163.MCT-19-0470.
Mol Cancer Ther. 2019.
PMID: 31160510
Free PMC article.
No abstract available.
Item in Clipboard
Bcl-2 antagonists interact synergistically with bortezomib in DLBCL cells in association with JNK activation and induction of ER stress.
Dasmahapatra G, Lembersky D, Rahmani M, Kramer L, Friedberg J, Fisher RI, Dent P, Grant S.
Dasmahapatra G, et al. Among authors: lembersky d.
Cancer Biol Ther. 2009 May;8(9):808-19. doi: 10.4161/cbt.8.9.8131. Epub 2009 May 8.
Cancer Biol Ther. 2009.
PMID: 19270531
Free PMC article.
Item in Clipboard
Carfilzomib interacts synergistically with histone deacetylase inhibitors in mantle cell lymphoma cells in vitro and in vivo.
Dasmahapatra G, Lembersky D, Son MP, Attkisson E, Dent P, Fisher RI, Friedberg JW, Grant S.
Dasmahapatra G, et al. Among authors: lembersky d.
Mol Cancer Ther. 2011 Sep;10(9):1686-97. doi: 10.1158/1535-7163.MCT-10-1108. Epub 2011 Jul 12.
Mol Cancer Ther. 2011.
PMID: 21750224
Free PMC article.
Retracted.
Item in Clipboard
Obatoclax interacts synergistically with the irreversible proteasome inhibitor carfilzomib in GC- and ABC-DLBCL cells in vitro and in vivo.
Dasmahapatra G, Lembersky D, Son MP, Patel H, Peterson D, Attkisson E, Fisher RI, Friedberg JW, Dent P, Grant S.
Dasmahapatra G, et al. Among authors: lembersky d.
Mol Cancer Ther. 2012 May;11(5):1122-32. doi: 10.1158/1535-7163.MCT-12-0021. Epub 2012 Mar 12.
Mol Cancer Ther. 2012.
PMID: 22411899
Free PMC article.
Retracted.
Item in Clipboard
The pan-HDAC inhibitor vorinostat potentiates the activity of the proteasome inhibitor carfilzomib in human DLBCL cells in vitro and in vivo.
Dasmahapatra G, Lembersky D, Kramer L, Fisher RI, Friedberg J, Dent P, Grant S.
Dasmahapatra G, et al. Among authors: lembersky d.
Blood. 2010 Jun 3;115(22):4478-87. doi: 10.1182/blood-2009-12-257261. Epub 2010 Mar 16.
Blood. 2010.
PMID: 20233973
Free PMC article.
Retracted.
Item in Clipboard
Cite
Cite